The Biotech is pretty flat in the last 7 days, but CanBas has stood out, gaining 38%. Unfortunately though, the industry is down 16% over the past 12 months. Looking forward, earnings are forecast to grow by 25% annually.
Has the Japanese Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 03 Feb 2023 | JP¥946.6b | JP¥186.7b | -JP¥24,854,541,000.00 | 39.7x | -38.1x | 5.1x |
Sun, 01 Jan 2023 | JP¥930.2b | JP¥186.8b | -JP¥24,722,604,000.00 | 44.6x | -37.6x | 5x |
Tue, 29 Nov 2022 | JP¥896.3b | JP¥182.1b | -JP¥23,614,604,000.00 | 45.3x | -38x | 4.9x |
Thu, 27 Oct 2022 | JP¥855.5b | JP¥176.5b | -JP¥24,974,270,000.00 | 48.2x | -34.3x | 4.8x |
Sat, 24 Sep 2022 | JP¥866.5b | JP¥176.5b | -JP¥24,974,270,000.00 | 44.2x | -34.7x | 4.9x |
Mon, 22 Aug 2022 | JP¥959.9b | JP¥174.4b | -JP¥21,144,270,000.00 | 21.8x | -45.4x | 5.5x |
Wed, 20 Jul 2022 | JP¥944.8b | JP¥171.3b | -JP¥16,112,943,000.00 | 21.3x | -58.6x | 5.5x |
Fri, 17 Jun 2022 | JP¥832.3b | JP¥171.3b | -JP¥16,658,721,000.00 | 21.3x | -50x | 4.9x |
Sun, 15 May 2022 | JP¥937.9b | JP¥169.1b | -JP¥12,813,215,000.00 | 12x | -73.2x | 5.5x |
Tue, 12 Apr 2022 | JP¥1.1t | JP¥164.2b | -JP¥13,043,295,000.00 | 15.2x | -82.2x | 6.5x |
Thu, 10 Mar 2022 | JP¥983.5b | JP¥164.1b | -JP¥9,674,798,000.00 | 14.5x | -101.7x | 6x |
Sat, 05 Feb 2022 | JP¥1.0t | JP¥163.7b | -JP¥5,383,446,000.00 | 16.1x | -193.5x | 6.4x |
Mon, 03 Jan 2022 | JP¥1.2t | JP¥163.5b | -JP¥5,447,524,000.00 | 18.4x | -226x | 7.5x |
Wed, 01 Dec 2021 | JP¥1.3t | JP¥159.5b | -JP¥8,763,358,000.00 | n/a | -145.3x | 8x |
Fri, 29 Oct 2021 | JP¥1.4t | JP¥147.6b | -JP¥12,269,440,000.00 | 23.4x | -112.2x | 9.3x |
Sun, 26 Sep 2021 | JP¥1.6t | JP¥147.6b | -JP¥12,269,440,000.00 | 26.1x | -133.3x | 11.1x |
Tue, 24 Aug 2021 | JP¥1.7t | JP¥148.3b | -JP¥14,096,440,000.00 | 24.7x | -117.2x | 11.1x |
Wed, 30 Jun 2021 | JP¥1.9t | JP¥139.5b | -JP¥15,500,440,000.00 | 33.2x | -122.9x | 13.7x |
Sat, 03 Apr 2021 | JP¥1.9t | JP¥122.0b | -JP¥18,475,632,000.00 | 61.1x | -102.2x | 15.5x |
Tue, 05 Jan 2021 | JP¥1.8t | JP¥103.8b | -JP¥25,953,087,000.00 | 125.6x | -68.8x | 17.2x |
Fri, 09 Oct 2020 | JP¥1.9t | JP¥84.8b | -JP¥26,206,135,000.00 | 146.4x | -74.2x | 22.9x |
Thu, 02 Jul 2020 | JP¥1.9t | JP¥78.3b | -JP¥27,486,602,000.00 | 139.8x | -68.1x | 23.9x |
Sun, 05 Apr 2020 | JP¥1.2t | JP¥78.5b | -JP¥32,046,297,000.00 | 178x | -38.1x | 15.6x |
-51.2x
Which industries have driven the changes within the Japanese Healthcare industry?
JP Market | -0.51% | |
Healthcare | -3.11% | |
Biotech | -0.64% | |
Biotech | -0.64% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
4575 CanBas | JP¥1.70k | 37.7% +JP¥7.4b | 628.3% | PB20.9x | |
4591 Ribomic | JP¥202.00 | 9.2% +JP¥606.8m | 0% | PS92.4x | |
2160 GNI Group | JP¥1.23k | 1.0% +JP¥569.8m | 6.5% | PE68.7x | |
4884 Kringle Pharma | JP¥732.00 | 5.2% +JP¥193.7m | 13.8% | PS10.1x | |
7774 Japan Tissue Engineering | JP¥506.00 | 0.6% +JP¥121.8m | 0% | PS10.5x |